New Prostate Cancer Drug Shows Promise against COVID-19
Michigan Medicine - University of Michigan
Researchers look into a drug called proxalutamide as a potential therapeutic for the coronavirus
Prostate Cancer
Biomarkers for Prostate Cancer Risk in Black Men Identified
City of Hope
Genetic, molecular changes in Black men with diabetes and prostate cancer could be developed into a precise diagnostic tool
Genetic Correction of PSA Levels May Improve Prostate Cancer Detection Accuracy
University of California - San Francisco
Inherited genetic determinants can cause normal variations in PSA levels even in the absence of prostate cancer
Lack of Racial Groups' Inclusion Negatively Impacts Cancer Research
National Comprehensive Cancer Network
Researchers call for better inclusion of men in Africa and with African ancestry to address disparities in prostate cancer outcomes
New ML Model Improves Prostate Cancer Recurrence Prediction
Elsevier
Machine learning model combines fusion gene expression, serum PSA level, and Gleason score to accurately predict cancer recurrence
A Blood Test That May Revolutionize Prostate Cancer Diagnosis
Swathi Kodaikal, MSc
Noninvasive test to precisely detect “micrometastases” and drive targeted therapy
Genetic Testing for Prostate Cancer after Introduction of Point-of-Care Program
Wolters Kluwer Health
The new protocol approximately tripled the rate of patient compliance with recommended genetic testing
New Prostate Cancer Diagnostic Pathway Paves Way for General Screening
University of Gothenburg
The risk of overdiagnosis is a hudtle to general screening that could be overcome with this new pathway
Considering Genetic Risk in Prostate Cancer Referrals
University of Exeter
Men at the highest risk for prostate cancer could be fast-tracked for investigation if their genetic risk was considered
Prostate Cancer Risks Being Detected Too Late Due to Focus on Urinary Problems
University of Cambridge
There is little to no evidence of a link between urinary symptoms and prostate cancer